CN101065122A - 输送鼻孔喷雾剂的方法 - Google Patents

输送鼻孔喷雾剂的方法 Download PDF

Info

Publication number
CN101065122A
CN101065122A CNA2005800402263A CN200580040226A CN101065122A CN 101065122 A CN101065122 A CN 101065122A CN A2005800402263 A CNA2005800402263 A CN A2005800402263A CN 200580040226 A CN200580040226 A CN 200580040226A CN 101065122 A CN101065122 A CN 101065122A
Authority
CN
China
Prior art keywords
mentioned
olopatadine
spraying
spray
axis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2005800402263A
Other languages
English (en)
Chinese (zh)
Inventor
G·卡格尔
G·M·沃尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alcon Inc
Original Assignee
Alcon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Inc filed Critical Alcon Inc
Publication of CN101065122A publication Critical patent/CN101065122A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L9/00—Disinfection, sterilisation or deodorisation of air
    • A61L9/015—Disinfection, sterilisation or deodorisation of air using gaseous or vaporous substances, e.g. ozone
    • A61L9/04—Disinfection, sterilisation or deodorisation of air using gaseous or vaporous substances, e.g. ozone using substances evaporated in the air without heating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
    • A61M11/006—Sprayers or atomisers specially adapted for therapeutic purposes operated by applying mechanical pressure to the liquid to be sprayed or atomised
    • A61M11/007—Syringe-type or piston-type sprayers or atomisers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0001—Details of inhalators; Constructional features thereof
    • A61M15/0021—Mouthpieces therefor
    • A61M15/0025—Mouthpieces therefor with caps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/08—Inhaling devices inserted into the nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05B—SPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES
    • B05B11/00—Single-unit hand-held apparatus in which flow of contents is produced by the muscular force of the operator at the moment of use
    • B05B11/01—Single-unit hand-held apparatus in which flow of contents is produced by the muscular force of the operator at the moment of use characterised by the means producing the flow
    • B05B11/10—Pump arrangements for transferring the contents from the container to a pump chamber by a sucking effect and forcing the contents out through the dispensing nozzle

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mechanical Engineering (AREA)
  • Inorganic Chemistry (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CNA2005800402263A 2004-11-24 2005-10-31 输送鼻孔喷雾剂的方法 Pending CN101065122A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63088604P 2004-11-24 2004-11-24
US60/630,886 2004-11-24

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CN201410053676.7A Division CN103860540A (zh) 2004-11-24 2005-10-31 奥洛他定在治疗鼻子过敏或发炎状态的制剂制备中的用途

Publications (1)

Publication Number Publication Date
CN101065122A true CN101065122A (zh) 2007-10-31

Family

ID=36498400

Family Applications (2)

Application Number Title Priority Date Filing Date
CNA2005800402263A Pending CN101065122A (zh) 2004-11-24 2005-10-31 输送鼻孔喷雾剂的方法
CN201410053676.7A Pending CN103860540A (zh) 2004-11-24 2005-10-31 奥洛他定在治疗鼻子过敏或发炎状态的制剂制备中的用途

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN201410053676.7A Pending CN103860540A (zh) 2004-11-24 2005-10-31 奥洛他定在治疗鼻子过敏或发炎状态的制剂制备中的用途

Country Status (19)

Country Link
US (3) US20060110328A1 (enExample)
EP (1) EP1814538B1 (enExample)
JP (1) JP5068172B2 (enExample)
KR (1) KR101158603B1 (enExample)
CN (2) CN101065122A (enExample)
AT (1) ATE443516T1 (enExample)
AU (1) AU2005309951B2 (enExample)
BR (1) BRPI0518283A2 (enExample)
CA (1) CA2586553C (enExample)
CY (1) CY1110528T1 (enExample)
DE (1) DE602005016833D1 (enExample)
DK (1) DK1814538T3 (enExample)
ES (1) ES2331619T3 (enExample)
MX (1) MX2007005845A (enExample)
PL (1) PL1814538T3 (enExample)
PT (1) PT1814538E (enExample)
SI (1) SI1814538T1 (enExample)
WO (1) WO2006057769A2 (enExample)
ZA (1) ZA200704139B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103221228A (zh) * 2010-11-22 2013-07-24 马丁·查德 标记设备及方法

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6788460B2 (en) 1998-04-15 2004-09-07 Duke University Projection screen apparatus
US6829087B2 (en) 1998-04-15 2004-12-07 Bright View Technologies, Inc. Micro-lens array based light transmitting screen with tunable gain
US6816306B2 (en) 1998-04-15 2004-11-09 Bright View Technologies Inc. Micro-lens array based light transmitting screen with high resolution and low imaging artifacts
US7977376B2 (en) * 2001-06-27 2011-07-12 Novartis Ag Olopatadine formulations for topical nasal administration
CA2677631C (en) 2007-02-07 2014-05-13 Alcon, Inc. Olopatadine formulations for topical nasal administration
CN102470099A (zh) * 2009-07-17 2012-05-23 爱尔康研究有限公司 儿童用奥洛他定鼻腔喷雾方案
WO2011027322A1 (en) 2009-09-03 2011-03-10 Ranbaxy Laboratories Limited Extended release dosage form containing olopatadine for oral administration
US9937189B2 (en) * 2013-09-13 2018-04-10 Glenmark Specialty S.A. Stable fixed dose pharmaceutical composition comprising mometasone and olopatadine
US9370483B2 (en) 2013-09-13 2016-06-21 Glenmark Specialty S.A. Stable fixed dose pharmaceutical composition comprising mometasone and olopatadine
PH12016500433B1 (en) 2013-09-13 2023-03-01 Glenmark Pharmaceuticals Ltd Stable fixed dose pharmaceutical composition comprising mometasone and olopatadine
US10548907B2 (en) 2013-10-04 2020-02-04 Glenmark Specialty S.A. Treatment of allergic rhinitis using a combination of mometasone and olopatadine
US10653661B2 (en) 2013-10-04 2020-05-19 Glenmark Specialty S.A. Treatment of allergic rhinitis using a combination of mometasone and olopatadine
MX2015009429A (es) 2013-10-04 2015-10-09 Glenmark Pharmaceuticals Ltd Tratamiento de rinitis alergica utilizando una combinacion de mometasona y olopatadina.
US10016443B2 (en) 2013-10-04 2018-07-10 Glenmark Specialty S.A. Treatment of allergic rhinitis using a combination of mometasone and olopatadine
US10758550B2 (en) 2013-10-04 2020-09-01 Glenmark Specialty S.A. Treatment of allergic rhinitis using a combination of mometasone and olopatadine
CN104063850B (zh) * 2014-06-24 2017-02-01 广东互维科技有限公司 红眼修复方法
US11679210B2 (en) 2014-10-03 2023-06-20 Glenmark Specialty S.A. Dispensing device and pharmaceutical composition for the treatment of rhinitis
CN107569454B (zh) * 2017-09-29 2018-05-04 深圳大佛药业股份有限公司 一种盐酸奥洛他定鼻喷雾剂及其制备方法
US12303635B2 (en) 2018-04-16 2025-05-20 Glenmark Specialty S.A. Dispensing device and pharmaceutical composition for the treatment of rhinitis
US11890409B1 (en) * 2019-11-19 2024-02-06 Saeed Rezakhany Methods of curing early stages of, and preventing, upper respiratory infections and applicators therefor
USD969992S1 (en) * 2020-12-23 2022-11-15 Aptar France Sas Device for nasal spray
US20250325582A1 (en) * 2022-03-02 2025-10-23 Vijay Duggal A hydrogen peroxide-based therapeutic spray for protection and treatment of mucosa

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE555319A (enExample) * 1956-03-21 1900-01-01
US4923892A (en) * 1985-08-17 1990-05-08 Burroughs Wellcome Co. Tricyclic aromatic compounds
GB8520662D0 (en) * 1985-08-17 1985-09-25 Wellcome Found Tricyclic aromatic compounds
JPS6310784A (ja) * 1986-03-03 1988-01-18 Kyowa Hakko Kogyo Co Ltd 抗アレルギー剤
PT88255B (pt) * 1987-08-13 1995-03-01 Glaxo Group Ltd Processo para a preparacao de derivados do indole
JPH0323237U (enExample) * 1989-07-19 1991-03-11
US5641805A (en) * 1995-06-06 1997-06-24 Alcon Laboratories, Inc. Topical ophthalmic formulations for treating allergic eye diseases
US5976573A (en) * 1996-07-03 1999-11-02 Rorer Pharmaceutical Products Inc. Aqueous-based pharmaceutical composition
FR2803612B1 (fr) * 2000-01-12 2002-12-06 Michel Jean Louis Mar Doustaly Point d'eau sanitaire adaptable a une cuvette de wc
GB0014892D0 (en) * 2000-06-16 2000-08-09 Glaxo Group Ltd Novel pharmaceutical formulation
IT1317998B1 (it) * 2000-06-26 2003-07-21 Medical Internat Licensing N V Valvola erogatrice per spray nasale.
TWI231759B (en) * 2001-06-27 2005-05-01 Alcon Inc Olopatadine formulations for topical administration
EP1426059A4 (en) * 2001-09-14 2007-01-17 Ono Pharmaceutical Co DRUGS FOR TREATING PRURIT
PL376970A1 (pl) * 2002-11-12 2006-01-23 Alcon, Inc. Zastosowanie środka przeciwalergicznego i steroidu do leczenia alergicznego nieżytu nosa
US7812120B2 (en) * 2003-03-21 2010-10-12 Par Pharmaceutical, Inc. Nasal calcitonin formulations containing chlorobutanol

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103221228A (zh) * 2010-11-22 2013-07-24 马丁·查德 标记设备及方法
CN103221228B (zh) * 2010-11-22 2016-03-02 马丁·查德 标记设备及方法

Also Published As

Publication number Publication date
PL1814538T3 (pl) 2010-02-26
MX2007005845A (es) 2007-07-04
ES2331619T3 (es) 2010-01-11
US20060110328A1 (en) 2006-05-25
EP1814538A4 (en) 2007-11-07
WO2006057769A2 (en) 2006-06-01
PT1814538E (pt) 2009-11-10
AU2005309951B2 (en) 2011-07-07
BRPI0518283A2 (pt) 2008-11-11
ATE443516T1 (de) 2009-10-15
CN103860540A (zh) 2014-06-18
CA2586553C (en) 2015-02-10
EP1814538B1 (en) 2009-09-23
US20140227326A1 (en) 2014-08-14
KR101158603B1 (ko) 2012-07-09
AU2005309951A1 (en) 2006-06-01
DK1814538T3 (da) 2009-11-02
KR20070086638A (ko) 2007-08-27
JP2008521488A (ja) 2008-06-26
CY1110528T1 (el) 2015-04-29
DE602005016833D1 (de) 2009-11-05
EP1814538A2 (en) 2007-08-08
CA2586553A1 (en) 2006-06-01
ZA200704139B (en) 2008-10-29
JP5068172B2 (ja) 2012-11-07
SI1814538T1 (sl) 2010-01-29
WO2006057769A3 (en) 2006-08-31
US20170172974A1 (en) 2017-06-22

Similar Documents

Publication Publication Date Title
CN101065122A (zh) 输送鼻孔喷雾剂的方法
EP2106268B1 (en) Aerosol generating and delivery device
US8642015B2 (en) Treatment of active infections and related compositions
CA2648553C (en) Sprayable gel-type skin/mucosa-adhesive preparation and administration system using the preparation
US20070193577A1 (en) Disodium cromoglycate compositions and methods for administering same
JPH07265425A (ja) 眼科用液体調合物を目に投与する方法、及び、そのためのスプレ装置
AU8102298A (en) A method for administration of active substances to the olfactory region
US20250177668A1 (en) Nasal Spray Device and Method of Nebulizing a Liquid Formulation
JP2008540034A (ja) 経口薬物送達システムおよびその使用方法
EP1487409B1 (en) Highly aqueous liquid carrier formulations
US20230355898A1 (en) Nebulizer and nebulized anti-virals
CN108883079A (zh) 喷雾剂、喷雾装置以及喷雾组件
Varsha et al. An overview study on nasal and intranasal delivery system of drug

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20071031